Crewe Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$160K	Hold	11,543	–	–	0.01%	228
2025 Q4	$187K	Hold	11,543	–	–	0.02%	211
2025 Q3	$173K	Hold	11,543	–	–	0.02%	228
2025 Q2	$134K	Hold	11,543	–	–	0.02%	193
2025 Q1	$85.8K	Hold	11,543	–	–	0.01%	215
2024 Q4	$69.2K	Hold	11,543	–	–	0.01%	250
2024 Q3	$59.1K	Sell	11,543 -47,595	-80%	-$207K	0.01%	281
2024 Q2	$214K	Hold	59,138	–	–	0.02%	173
2024 Q1	$190K	Sell	59,138 -600	-1%	-$2.32K	0.02%	174
2023 Q4	$293K	Hold	59,738	–	–	0.05%	60
2023 Q3	$326K	Hold	59,738	–	–	0.06%	59
2023 Q2	$401K	Hold	59,738	–	–	0.06%	89
2023 Q1	$527K	Hold	59,738	–	–	0.08%	81
2022 Q4	$456K	Sell	59,738 -113	-0.2%	-$879	0.07%	83
2022 Q3	$426K	Hold	59,851	–	–	0.08%	82
2022 Q2	$484K	Buy	59,851 +613	+1%	+$5.39K	0.11%	60
2022 Q1	$822K	Buy	59,238 +100	+0.2%	+$1.57K	0.16%	34
2021 Q4	$1.66M	Hold	59,138	–	–	0.34%	24
2021 Q3	$2.01M	Hold	59,138	–	–	0.48%	18
2021 Q2	$2.42M	Hold	59,138	–	–	0.6%	17
2021 Q1	$2.38M	Hold	59,138	–	–	0.59%	18
2020 Q4	$3.5M	Sell	59,138 -16,870	-22%	-$870K	1.4%	17
2020 Q3	$3.7M	Sell	76,008 -5,410	-7%	-$227K	1.73%	13
2020 Q2	$3.94M	Sell	81,418 -11,582	-12%	-$422K	1.92%	11
2020 Q1	$2.58M	Buy	+93,000	New	+$2.59M	1.54%	13